These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23341860)

  • 1. The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.
    Grabowska AK; Riemer AB
    Open Virol J; 2012; 6():249-56. PubMed ID: 23341860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interplay between Antiviral Signalling and Carcinogenesis in Human Papillomavirus Infections.
    Ferreira AR; Ramalho AC; Marques M; Ribeiro D
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection.
    Senba M; Mori N
    Oncol Rev; 2012 Oct; 6(2):e17. PubMed ID: 25992215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer.
    Hatano T; Sano D; Takahashi H; Oridate N
    Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33919460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
    Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
    mBio; 2016 May; 7(3):. PubMed ID: 27143385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.
    Raikhy G; Woodby BL; Scott ML; Shin G; Myers JE; Scott RS; Bodily JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System.
    Zhou C; Tuong ZK; Frazer IH
    Front Oncol; 2019; 9():682. PubMed ID: 31428574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune therapy for human papillomaviruses-related cancers.
    Rosales R; Rosales C
    World J Clin Oncol; 2014 Dec; 5(5):1002-19. PubMed ID: 25493236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms used by human papillomaviruses to escape the host immune response.
    Kanodia S; Fahey LM; Kast WM
    Curr Cancer Drug Targets; 2007 Feb; 7(1):79-89. PubMed ID: 17305480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
    Sasagawa T; Takagi H; Makinoda S
    J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between human papillomaviruses and dendritic cells.
    Offringa R; de Jong A; Toes RE; van der Burg SH; Melief CJ
    Curr Top Microbiol Immunol; 2003; 276():215-40. PubMed ID: 12797450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.
    Woodby BL; Songock WK; Scott ML; Raikhy G; Bodily JM
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of infection by human papillomavirus.
    Brendle SA; Bywaters SM; Christensen ND
    Curr Probl Dermatol; 2014; 45():47-57. PubMed ID: 24643177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
    Conesa-Zamora P
    Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the IFN-Pathway by Human Papillomavirus Proteins: Antiviral Immune Response Evasion Mechanism.
    Castro-Muñoz LJ; Rocha-Zavaleta L; Lizano M; Ramírez-Alcántara KM; Madrid-Marina V; Manzo-Merino J
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.
    Song D; Li H; Li H; Dai J
    Oncol Lett; 2015 Aug; 10(2):600-606. PubMed ID: 26622540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.
    Scott ML; Woodby BL; Ulicny J; Raikhy G; Orr AW; Songock WK; Bodily JM
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.
    Venuti A; Lohse S; Tommasino M; Smola S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180287. PubMed ID: 30955489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.